Balan V.E.
Tikhomirova E.V.
Tsarkova A.V.
Gadgieva Z.K.
GBUZ MO Moscow Regional Scientific and Research Institute of Obstetrics and Gynecology, Moscow, Russia.
FGAOU VO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia, Moscow, Russia.
Current aspects of the treatment of urogenital atrophy (based on the consensus of britain society of menopause)
Текст визуальный электронный
Urologiia (Moscow, Russia : 1999)
№ 5 С. 150-154
2019
dyspareunia
genitourinary syndrome of menopause (GSM) dryness
non- sexual dysfunction
non-hormonal moisturizers
pruritus
pseudocystitis
urine incontinence
vaginal estrogens
Статья
Обзор
Atrophy diagnosis C23.300.070
Atrophy etiology C23.300.070
Atrophy therapy C23.300.070
Атрофия диагностика C23.300.070
Атрофия этиология C23.300.070
Атрофия терапия C23.300.070
Consensus F01.829.316.068 F02.463.785.373.433
Консенсус F01.829.316.068 F02.463.785.373.433
Female
Женский
Humans B01.050.150.900.649.313.988.400.112.400.400
Человек B01.050.150.900.649.313.988.400.112.400.400
Lubricants therapeutic use D27.720.556
Лубриканты терапевтическое применение D27.720.556
Menopause G08.686.157.500 G08.686.841.249.500
Менопауза G08.686.157.500 G08.686.841.249.500
Sexual Dysfunction, Physiological therapy C12.100.875
Сексуальная дисфункция физиологическая терапия C12.100.875
United Kingdom Z01.542.363
Соединенное Королевство Z01.542.363
Vagina pathology A05.360.319.779
Влагалище патология A05.360.319.779
Vaginal Diseases therapy C12.050.351.500.894 C12.100.250.894
Влагалища болезни терапия C12.050.351.500.894 C12.100.250.894
Vulva pathology A05.360.319.887
Вульва патология A05.360.319.887
Journal Article V02.600
Журнальная статья V02.600
Review V02.600.500 V02.912
Обзор V02.600.500 V02.912
The symptoms of genitourinary syndrome of menopause are considered as typical for late menopausal period. However, these symptoms are increasingly diagnosed in perimenopausal and early menopausal period. Women seldom seek medical care, since autonomic menopausal symptoms are usually more bothersome. In many cases, doctors are not sure in necessity of any hormonal replacement. Moreover, a confusion still exists between systemic hormone replacement therapy (HRT) and local estrogen preparations. Besides moisturizers and local intravaginal estrogens, novel treatment modalities have emerged that extend therapeutic armamentarium.